Expanded Functionality to Support COVID-19 Research Immediately Available Through Early Access
“ROSALIND offers powerful data analysis capabilities and a unique ability to facilitate collaboration amongst researchers,” said
ROSALIND is a cloud platform that connects researchers to differential expression and pathway exploration in a real-time collaborative environment. The companies are working to make the popular features of NanoString’s nSolver™
The nCounter platform has been used in over 300 published studies of infectious disease on host immune response, including more than four COVID-19 publications. Its high-plex and wide dynamic range enable studies of pathogen and host gene expression profiles simultaneously with a wide range of sample types. The company announced the availability of a beta panel spike in for COVID-19 research in April and has over 50 customers utilizing the reagents in their research.
“We are excited to partner with
To learn more about the ways that NanoString’s products enable researchers to rapidly answer questions related to infectious diseases, including COVID-19, please visit https://www.nanostring.com/scientific-content/infectious-disease.
For more information, please visit www.nanostring.com.
Vice President, Investor Relations & Corporate Communications
Investor Relations & Communications Officer